PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $45,000 | +150.0% | 5,168 | +209.3% | 0.00% | – |
Q3 2019 | $18,000 | -5.3% | 1,671 | +13.5% | 0.00% | – |
Q2 2019 | $19,000 | -77.6% | 1,472 | -32.1% | 0.00% | -100.0% |
Q1 2019 | $85,000 | +608.3% | 2,169 | +253.8% | 0.00% | – |
Q4 2018 | $12,000 | -62.5% | 613 | -11.3% | 0.00% | – |
Q3 2018 | $32,000 | -69.5% | 691 | -55.3% | 0.00% | -100.0% |
Q2 2018 | $105,000 | 0.0% | 1,547 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $105,000 | +176.3% | 1,547 | +307.1% | 0.00% | – |
Q4 2017 | $38,000 | -15.6% | 380 | +1.6% | 0.00% | – |
Q3 2017 | $45,000 | +36.4% | 374 | 0.0% | 0.00% | – |
Q2 2017 | $33,000 | +135.7% | 374 | 0.0% | 0.00% | – |
Q1 2017 | $14,000 | +27.3% | 374 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | +120.0% | 374 | +405.4% | 0.00% | – |
Q3 2016 | $5,000 | +150.0% | 74 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q1 2016 | $2,000 | -91.3% | 74 | -75.3% | 0.00% | – |
Q4 2015 | $23,000 | -57.4% | 299 | -57.8% | 0.00% | -100.0% |
Q3 2015 | $54,000 | -29.9% | 709 | +7.6% | 0.00% | 0.0% |
Q2 2015 | $77,000 | -53.9% | 659 | -6.9% | 0.00% | -66.7% |
Q1 2015 | $167,000 | +26.5% | 708 | +1.3% | 0.00% | 0.0% |
Q4 2014 | $132,000 | -42.1% | 699 | -26.9% | 0.00% | -50.0% |
Q3 2014 | $228,000 | +5600.0% | 956 | +1670.4% | 0.01% | – |
Q2 2014 | $4,000 | +300.0% | 54 | +671.4% | 0.00% | – |
Q1 2014 | $1,000 | – | 7 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |